Track Categories
The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.
Cancer Research focuses on understanding the biological, genetic, and environmental factors driving cancer initiation and progression. This session highlights basic, translational, and clinical research aimed at discovering novel mechanisms, biomarkers, and therapeutic targets to improve early detection, treatment outcomes, and patient survival across diverse cancer types.
Sub-sessions:
- Cancer Biology
- Translational Research
- Tumor Microenvironment
- Biomarker Discovery
- Experimental Oncology
2. Treatment
The Treatment session covers current and emerging cancer therapies, emphasizing personalized and multidisciplinary approaches. Topics include medical, surgical, and radiation-based treatments, combination therapies, and patient-centered care strategies designed to enhance efficacy, minimize side effects, and improve quality of life for cancer patients.
Sub-sessions:
- Targeted Therapy
- Immunotherapy Advances
- Combination Treatment
- Precision Medicine
- Patient Outcomes
Molecular Oncology explores cancer at the molecular and cellular levels, focusing on oncogenes, tumor suppressors, signaling pathways, and epigenetic changes. This session emphasizes how molecular insights drive precision diagnostics and targeted therapies, enabling more accurate treatment selection and improved therapeutic responses.
Sub-sessions:
- Oncogenic Pathways
- Molecular Targets
- Signal Transduction
- Epigenetic Regulation
- Precision Oncology
This session examines the mechanisms underlying tumor growth, invasion, and metastatic spread. Discussions focus on angiogenesis, tumor microenvironment interactions, immune evasion, and metastatic niches, offering insights into strategies to prevent cancer dissemination and improve long-term patient prognosis.
Sub-sessions:
- Metastatic Mechanisms
- Tumor Angiogenesis
- Cell Migration
- Microenvironment Dynamics
- Invasion Biology
Advances in Cancer Diagnosis highlight innovative technologies for early and accurate cancer detection. Topics include molecular diagnostics, imaging advancements, liquid biopsies, and AI-driven diagnostic tools, aiming to improve screening accuracy, enable early intervention, and support personalized treatment planning.
Sub-sessions:
- Molecular Diagnostics
- Imaging Technologies
- Liquid Biopsies
- Early Detection
- Diagnostic Innovation
This session focuses on the discovery, design, and clinical evaluation of anticancer drugs. Emphasis is placed on novel compounds, targeted agents, biologics, and translational strategies that accelerate drug development pipelines and improve safety, efficacy, and regulatory success.
Sub-sessions:
- Drug Discovery
- Clinical Trials
- Therapeutic Design
- Pharmacological Innovation
- Translational Development
The Breast Cancer session addresses advances in prevention, diagnosis, and treatment of breast malignancies. Topics include molecular subtypes, targeted therapies, resistance mechanisms, and survivorship care, with a focus on improving personalized treatment and long-term outcomes for patients.
Sub-sessions:
- Breast Subtypes
- Hormonal Therapy
- HER2 Targeting
- Resistance Mechanisms
- Survivorship Care
This session explores recent progress in lung cancer research, including molecular profiling, immunotherapy, early detection, and novel treatment approaches. Emphasis is placed on addressing high mortality rates through precision medicine and improved screening strategies.
Sub-sessions:
- Lung Oncology
- Immunotherapy Approaches
- Molecular Profiling
- Targeted Treatments
- Early Screening
Colorectal and GI Cancers sessions focus on malignancies of the gastrointestinal tract, highlighting molecular mechanisms, diagnostic biomarkers, and evolving therapeutic strategies. Discussions aim to improve early detection, treatment outcomes, and patient survival across GI cancer types.
Sub-sessions:
- GI Oncology
- Colorectal Pathways
- Digestive Cancers
- Molecular Markers
- Therapeutic Strategies
This session covers cancers affecting the female reproductive system, including ovarian, cervical, and endometrial cancers. Topics emphasize early diagnosis, molecular classification, targeted therapies, and preventive strategies to enhance patient care and survival rates.
Sub-sessions:
- Ovarian Cancer
- Cervical Oncology
- Endometrial Tumors
- Women’s Health
- Preventive Oncology
Hematological Cancers focus on malignancies of the blood, bone marrow, and lymphatic systems. This session explores molecular pathogenesis, diagnostic advancements, and novel therapies, including immunotherapy and stem cell transplantation.
Sub-sessions:
- Blood Malignancies
- Bone Marrow
- Lymphoid Disorders
- Molecular Hematology
- Targeted Therapy
Blood Cancer sessions emphasize leukemia, lymphoma, and myeloma research. Discussions include genetic alterations, treatment resistance, and innovative therapeutic approaches aimed at improving remission rates and long-term survival.
Sub-sessions:
- Leukemia Research
- Lymphoma Studies
- Myeloma Advances
- Genetic Alterations
- Clinical Management
This session explores genetic and genomic alterations driving cancer development. Topics include genome sequencing, hereditary cancer syndromes, and precision oncology approaches that enable personalized risk assessment and treatment planning.
Sub-sessions:
- Cancer Genomics
- Genetic Mutations
- Hereditary Syndromes
- Genome Sequencing
- Precision Diagnostics
Radiation Oncology & Radiobiology focuses on advances in radiotherapy technologies and biological responses to radiation. Discussions highlight precision radiation delivery, radiosensitizers, and strategies to minimize toxicity while maximizing tumor control.
Sub-sessions:
- Radiation Therapy
- Radiobiological Effects
- Precision Radiotherapy
- Treatment Planning
- Toxicity Reduction
This session examines traditional and modern chemotherapy approaches, including drug combinations, resistance mechanisms, and toxicity management. Emphasis is placed on optimizing regimens to improve efficacy while reducing adverse effects.
Sub-sessions:
- Chemotherapeutic Agents
- Drug Resistance
- Combination Therapy
- Toxicity Management
- Clinical Optimization
Carcinoma sessions focus on epithelial cancers, addressing molecular mechanisms, diagnostic challenges, and evolving treatment strategies. The goal is to enhance early detection and improve therapeutic outcomes across carcinoma subtypes.
Sub-sessions:
- Epithelial Tumors
- Molecular Pathways
- Diagnostic Challenges
- Therapeutic Approaches
- Disease Progression
Pediatric Oncology highlights cancers affecting children and adolescents, focusing on unique biological characteristics, treatment challenges, and survivorship issues. Emphasis is placed on reducing long-term side effects while improving cure rates.
Sub-sessions:
- Childhood Cancers
- Pediatric Tumors
- Developmental Oncology
- Survivorship Care
- Treatment Safety
This session explores the role of cancer stem cells in tumor initiation, progression, and therapy resistance. Discussions focus on targeting stem cell populations to prevent relapse and improve treatment durability.
Sub-sessions:
- Stem Cell Biology
- Tumor Initiation
- Therapy Resistance
- Cellular Plasticity
- Targeted Elimination
Cancer and Nutrition examines the relationship between diet, metabolism, and cancer progression. Topics include nutritional interventions, metabolic pathways, and supportive care strategies to enhance treatment tolerance and patient outcomes.
Sub-sessions:
- Cancer Metabolism
- Nutritional Support
- Dietary Interventions
- Patient Wellness
- Supportive Care
This session focuses on artificial intelligence and digital technologies transforming oncology. Topics include AI-driven diagnostics, predictive analytics, digital pathology, and personalized treatment planning to enhance accuracy and efficiency in cancer care.
Sub-sessions:
- AI Oncology
- Digital Pathology
- Predictive Analytics
- Smart Diagnostics
- Clinical Automation